Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.
Pavlinac PB, Rogawski McQuade ET, Platts-Mills JA, Kotloff KL, Deal C, Giersing BK, Isbrucker RA, Kang G, Ma LF, MacLennan CA, Patriarca P, Steele D, Vannice KS.
Pavlinac PB, et al. Among authors: maclennan ca.
Vaccines (Basel). 2022 Mar 22;10(4):489. doi: 10.3390/vaccines10040489.
Vaccines (Basel). 2022.
PMID: 35455238
Free PMC article.